USP22 competes with USP27X and USP51 for activation by ATXN7L3 and ENY2
USP27X and USP51 function independently of SAGA
ATXN7L3 and ENY2 availability is tightly regulated in cells
USP51 and USP27x ablation impairs cell proliferation and tumor progression